Breaking News Instant updates and real-time market news.

AZN

AstraZeneca

$33.26

0.865 (2.67%)

, TEVA

Teva

$32.79

-0.396 (-1.19%)

13:58
07/14/17
07/14
13:58
07/14/17
13:58

AstraZeneca up 4% after Bloomberg says CEO plans on staying

Shares of Teva (TEVA) are down 4% to $31.97.

AZN

AstraZeneca

$33.26

0.865 (2.67%)

TEVA

Teva

$32.79

-0.396 (-1.19%)

  • 19

    Jul

  • 03

    Aug

  • 30

    Aug

AZN AstraZeneca
$33.26

0.865 (2.67%)

07/05/17
SBSH
07/05/17
DOWNGRADE
SBSH
Neutral
GlaxoSmithKline downgraded to Neutral from Buy at Citi
Citi analyst Andrew Baum downgraded GlaxoSmithKline (GSK) to Neutral and lowered his price target for the shares to GBP 17 from GBP 18. The analyst believes the market is underappreciating the slowing of the company's HIV market growth. He prefers shares of AstraZeneca (AZN), Roche (RHHBY) and Bayer (BAYRY) for exposure to Europe.
07/13/17
LEER
07/13/17
NO CHANGE
LEER
Outperform
AstraZeneca CEO departure now would have 'terrible' optics, says Leerink
Leerink analyst Seamus Fernandez said the media report that AstraZeneca (AZN) CEO Pascal Soriot may be leaving the company to take over at Teva (TEVA) comes as a "major surprise," adding that while the company would not comment to him on the rumor it also did not outright deny the report. While the news does not appear to be related to the outcome of the MYSTIC trial in non-small cell lung cancer, the optics around such a departure at this would be "terrible" and his loss would be a "clear negative" for AstraZeneca, according to Fernandez, who has an Outperform rating on Astra shares.
07/13/17
SBSH
07/13/17
NO CHANGE
Target $42
SBSH
Buy
Teva landing Soriot would be 'material positive,' says Citi
Citi analyst Liav Abraham believes Calcalist's report of Teva (TEVA) hiring away AstraZeneca's (AZN) CEO Pascal Soriot has credibility given the "relatively accurate track record" of the Israeli press in the "leaking" of information pertaining to Teva. The news, if confirmed, would be a "material positive" for Teva over the near to medium term, Abraham tells investors in a research note. She believes Soriot would "lend significant credibility" to Teva's turnaround thesis. On the other side, Soriot leaving would increase concerns over the pending outcome of AstraZeneca's MYSTIC trial, which constitutes the dominant near-term driver for the shares, Abraham argues. She has a Buy rating on Teva with a $42 price target. The stock in premarket trading is up 2% to $32.80. AstraZeneca is down 14c to $32.78.
07/14/17
LEER
07/14/17
NO CHANGE
Target $36
LEER
Outperform
Leerink sees significant optionality for AstraZeneca beyond MYSTIC trial
Leerink analyst Seamus Fernandez said he sees significant optionality for AstraZeneca (AZN) beyond the "mega-catalyst" of the MYSTIC trial in non-small cell lung cancer, as he believes several 2017 and 2018 readouts from underappreciated pipeline assets could lead to upside for the shares. If MYSTIC fails, Astra's "massive" SG&A spend gives it flexibility to mute the bottom-line impact. If it is successful, he believes potential acquirers such as Pfizer (PFE) or Novartis (NVS) could see "an attractive target to plunder," Fernandez tells investors. He keeps an Outperform rating and $36 price target on AstraZeneca ADRs.
TEVA Teva
$32.79

-0.396 (-1.19%)

06/27/17
WELS
06/27/17
NO CHANGE
WELS
Market Perform
Teva TV-45070 trial miss a 'modest disappointment,' says Wells Fargo
Wells Fargo analyst David Maris said TV-45070 has not been a focus for Teva (TEVA) investors, but he still views the news that the company and partner Xenon Pharmaceuticals' (XENE) Phase 2 trial in post-herpetic neuralgia missed its primary endpoint as a "modest disappointment" given the need for Teva's pipeline to offset the tough generic market and the eventual competition for Copaxone. Maris keeps a Market Perform rating on Teva.
07/05/17
OPCO
07/05/17
NO CHANGE
Target $70
OPCO
Outperform
Neurocrine Ingrezza 'holds steady' after competitor data, says Oppenheimer
Oppenheimer analyst Jay Olson notes that Teva's (TEVA) Austedo could become a competitor to Neurocrine's (NBIX) Ingrezza with a PDUFA date for the tardive dyskinesia indication on August 30, 2017. However, the analyst sees Ingrezza as well positioned and reiterates an Outperform rating and $70 price target on Neurocrine's shares. A key factor to follow beyond the short trials will be real-life performance considering the number needed to treat to observe a 50% AIMS improvement was 5 for Austedo and 4 for Ingrezza, he contends.

TODAY'S FREE FLY STORIES

VIPS

Vipshop

$7.97

-1.015 (-11.30%)

09:47
08/14/18
08/14
09:47
08/14/18
09:47
Hot Stocks
Vipshop falls -11.6% »

Vipshop is down -11.6%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 10

    Sep

HUYA

HUYA

$28.05

-4.81 (-14.64%)

09:47
08/14/18
08/14
09:47
08/14/18
09:47
Hot Stocks
HUYA falls -14.4% »

HUYA is down -14.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWCH

Switch

$10.47

-3.49 (-25.00%)

09:47
08/14/18
08/14
09:47
08/14/18
09:47
Hot Stocks
Switch falls -25.1% »

Switch is down -25.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YUMC

Yum China

$36.25

2.03 (5.93%)

09:47
08/14/18
08/14
09:47
08/14/18
09:47
Hot Stocks
Yum China rises 6.1% »

Yum China is up 6.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

AAP

Advance Auto Parts

$153.90

9.11 (6.29%)

09:47
08/14/18
08/14
09:47
08/14/18
09:47
Hot Stocks
Advance Auto Parts rises 6.6% »

Advance Auto Parts is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

TPR

Tapestry

$51.19

3.77 (7.95%)

09:47
08/14/18
08/14
09:47
08/14/18
09:47
Hot Stocks
Tapestry rises 7.8% »

Tapestry is up 7.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 12

    Sep

AAP

Advance Auto Parts

$144.79

(0.00%)

09:44
08/14/18
08/14
09:44
08/14/18
09:44
Technical Analysis
Technical Take: Advance Auto Parts at new 52-week high after earnings »

In early trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

FB

Facebook

$180.08

(0.00%)

, BABA

Alibaba

$177.65

(0.00%)

09:44
08/14/18
08/14
09:44
08/14/18
09:44
Hot Stocks
Jana Partners buys Facebook and Alibaba in Q2, sells out of Northrop »

Barry Rosenstein's…

FB

Facebook

$180.08

(0.00%)

BABA

Alibaba

$177.65

(0.00%)

MSFT

Microsoft

$108.24

(0.00%)

WFC

Wells Fargo

$57.64

(0.00%)

GOOGL

Alphabet Class A

$1,248.76

(0.00%)

GOOG

Alphabet

$1,235.10

(0.00%)

BLMN

Bloomin' Brands

$18.13

(0.00%)

NOC

Northrop Grumman

$292.10

(0.00%)

KDP

Keurig Dr Pepper

$23.75

(0.00%)

WRK

WestRock

$54.73

(0.00%)

CI

Cigna

$181.78

(0.00%)

EA

Electronic Arts

$131.29

(0.00%)

A

Agilent

$65.95

(0.00%)

AAPL

Apple

$208.87

(0.00%)

TIF

Tiffany

$130.88

(0.00%)

LRCX

Lam Research

$178.13

(0.00%)

HDS

HD Supply

$43.72

(0.00%)

ADSK

Autodesk

$133.41

(0.00%)

BSX

Boston Scientific

$33.30

(0.00%)

ZBH

Zimmer Biomet

$122.45

(0.00%)

JACK

Jack in the Box

$89.03

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 15

    Aug

  • 15

    Aug

  • 19

    Aug

  • 20

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 23

    Aug

  • 23

    Aug

  • 23

    Aug

  • 24

    Aug

  • 28

    Aug

  • 04

    Sep

  • 10

    Sep

  • 11

    Sep

  • 12

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

  • 18

    Sep

  • 28

    Oct

  • 06

    Nov

  • 12

    Apr

  • 13

    Jul

  • 15

    Oct

F

Ford

$9.46

(0.00%)

, BABA

Alibaba

$177.65

(0.00%)

09:42
08/14/18
08/14
09:42
08/14/18
09:42
Hot Stocks
Ford-owned Autonomic announces partnership with Alibaba Cloud »

Autonomic, a wholly owned…

F

Ford

$9.46

(0.00%)

BABA

Alibaba

$177.65

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 23

    Aug

  • 31

    Aug

  • 10

    Sep

CMI

Cummins

$139.70

(0.00%)

, BZUN

Baozun

$52.66

(0.00%)

09:40
08/14/18
08/14
09:40
08/14/18
09:40
Options
Unusually active option classes on open August 14th »

Unusual total active…

CMI

Cummins

$139.70

(0.00%)

BZUN

Baozun

$52.66

(0.00%)

TPR

Tapestry

$47.42

(0.00%)

HD

Home Depot

$194.11

(0.00%)

SWN

Southwestern Energy

$5.34

(0.00%)

NWL

Newell Brands

$20.47

(0.00%)

XLE

Energy Select Sector SPDR

$74.30

(0.00%)

FXI

iShares China Large-Cap ETF

$42.15

(0.00%)

M

Macy's

$40.08

(0.00%)

BABA

Alibaba

$177.65

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 15

    Aug

  • 23

    Aug

  • 10

    Sep

  • 12

    Sep

  • 17

    Sep

09:40
08/14/18
08/14
09:40
08/14/18
09:40
General news
U.S. corporate bond update: issuance remains solid »

U.S. corporate bond…

DB

Deutsche Bank

$11.44

-0.375 (-3.17%)

09:39
08/14/18
08/14
09:39
08/14/18
09:39
Periodicals
Deutsche Bank to review contract of IB head Ritchie in Oct., Financial News says »

Deutsche Bank will review…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYNL

Synalloy

$23.55

(0.00%)

09:39
08/14/18
08/14
09:39
08/14/18
09:39
Hot Stocks
Breaking Hot Stocks news story on Synalloy »

Synalloy trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

SWCH

Switch

$13.96

-0.11 (-0.78%)

09:36
08/14/18
08/14
09:36
08/14/18
09:36
Recommendations
Switch analyst commentary  »

Switch price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$194.11

-2.19 (-1.12%)

09:35
08/14/18
08/14
09:35
08/14/18
09:35
Hot Stocks
Breaking Hot Stocks news story on Home Depot »

Home Depot says tariff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

F

Ford

$9.46

-0.275 (-2.82%)

09:33
08/14/18
08/14
09:33
08/14/18
09:33
Periodicals
Ford recalls nearly 4,000 cars in Russia, Reuters reports »

Ford is recalling 3,968…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 31

    Aug

CPT

Camden Property

$92.39

-0.01 (-0.01%)

09:31
08/14/18
08/14
09:31
08/14/18
09:31
Recommendations
Camden Property analyst commentary  »

Camden Property price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

09:30
08/14/18
08/14
09:30
08/14/18
09:30
General news
Stocks open higher as Turkey concerns ease »

Stock futures traded…

ABIL

Ability

$5.95

1.38 (30.20%)

09:30
08/14/18
08/14
09:30
08/14/18
09:30
Syndicate
Ability announces $3.35M registered direct offering »

Ability announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
08/14/18
08/14
09:30
08/14/18
09:30
General news
The U.S. July trade price report was weak »

The U.S. July trade price…

TPR

Tapestry

$47.42

-0.52 (-1.08%)

09:29
08/14/18
08/14
09:29
08/14/18
09:29
Hot Stocks
Tapestry expects 'modest' net decrease in Coach brand stores in FY19 »

Says will continue to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 12

    Sep

DHT

DHT Holdings

$4.31

-0.015 (-0.35%)

09:29
08/14/18
08/14
09:29
08/14/18
09:29
Downgrade
DHT Holdings rating change  »

DHT Holdings downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

ABIL

Ability

$5.95

1.38 (30.20%)

09:28
08/14/18
08/14
09:28
08/14/18
09:28
Syndicate
Ability announces registered direct offering »

Ability Inc. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGEN

Tecogen

$3.33

0.03 (0.91%)

09:25
08/14/18
08/14
09:25
08/14/18
09:25
Hot Stocks
Tecogen receives U.S. patent for catalyst formulation for Ultera emissions »

Tecogen has been granted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

MAR

Marriott

$120.48

0.23 (0.19%)

09:25
08/14/18
08/14
09:25
08/14/18
09:25
Upgrade
Marriott rating change  »

Marriott upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.